Brief: Spago Nanomedical Q4 Sales SEK 617 Thousand
Feb 06 (Reuters) - Spago Nanomedical Q4 adjusted EPS SEK -0.02. * Q4 operating expenses SEK -10.223 million * Q4 net income SEK -7.83 million
Feb 06 (Reuters) - Spago Nanomedical Q4 adjusted EPS SEK -0.02. * Q4 operating expenses SEK -10.223 million * Q4 net income SEK -7.83 million